Loading data
PACBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 114.23 m USD | 116.73 m USD | 147.74 m USD | 79.27 m USD | 71.65 m USD |
| Gross profit | 45.78 m USD | 37.28 m USD | 52.78 m USD | 49.04 m USD | 58.86 m USD |
| Research and development expense | 97.31 m USD | 134.92 m USD | 187.17 m USD | 193 m USD | 112.9 m USD |
| Selling, general and administrative expense | 141.49 m USD | 175.02 m USD | 169.82 m USD | 160.85 m USD | 124.12 m USD |
| Operating profit | -553.86 m USD | -474.31 m USD | -334.47 m USD | -307.2 m USD | -210.44 m USD |
| Interest expense | — | — | 14.34 m USD | 14.69 m USD | 12.53 m USD |
| Profit before tax | -546.06 m USD | -309.54 m USD | -318.16 m USD | -314.25 m USD | -274.87 m USD |
| Income tax expense | 318 k USD | 316 k USD | -11.42 m USD | 0 USD | -93.65 m USD |
| Net income (reported basis) | -546.4 m USD | -309.9 m USD | -306.7 m USD | -314.2 m USD | -181.2 m USD |
| Net income attributable to common shareholders | -546.38 m USD | -309.85 m USD | -306.74 m USD | -314.25 m USD | — |
| Basic earnings per share | -1.82 USD/share | -1.13 USD/share | -1.21 USD/share | -1.4 USD/share | -0.89 USD/share |
| Diluted earnings per share | -1.82 USD/share | -1.59 USD/share | -1.21 USD/share | -1.4 USD/share | -0.89 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.